FDA advisory committee recommends making the opioid and fentanyl overdose reversal drug Narcan available for retail sales.
Author: Ken Alltucker, USA TODAY
Medicare targets drug companies that raise prices above rate of inflation
Medicare’s rebate authority comes from the Inflation Reduction Act, which also empowers the federal government to negotiate drug prices.
Here’s why Medicaid coverage and free COVID tests, treatments will soon change
About 15 million may lose health insurance in May when the COVID emergency ends. Meanwhile, free vaccines and treatments will end by summer.
Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar
The price of Amgen’s rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.
Biden seeks to bolster the Affordable Care Act’s no-cost contraception rule
The proposed rule would remove an employer’s ability to object to contraceptive coverage on moral grounds while still allowing religious objections.
Why drugmakers have raised prices on nearly 1,000 drugs so far this year
Pharma companies raise prices on nearly 1,000 drugs as the Inflation Reduction Act phases in new federal restrictions in coming years. What to know.
Medicare launches plan to negotiate prices for the costliest drugs. Here’s what to know.
As part of the Inflation Reduction Act, Medicare will negotiate drug prices, limit annual price hikes and cap insulin costs paid by older Americans.
Half of ambulance rides yield surprise medical bills. What’s being done to protect people?
No Surprises Act protects consumers from costly surprise bills during emergency medical care, but not from ambulance bills.
Here’s why private Medicare plans are set to pass traditional Medicare enrollment
More than 28 million older adults enrolled in Medicare plans administered by private insurance companies rather than the federal government.
‘Calm before the storm’: Health insurance costs set to spike after they stayed mostly flat in 2022, survey finds
Kaiser Family Foundation survey reports average cost for an employer-provided health increased just 1% this year.